NCT06764966View on ClinicalTrials.gov

Statin and Beta Blocker Use in Patients with Decompensated Cirrhosis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Decompensated Liver CirrhosisCirrhosisDecompensated Cirrhosis of LiverDecompensated Cirrhosis and Ascites
Interventions
DRUG

Atorvastatin 20 mg

Atorvastatin 20 mg Once Daily with previously prescribed Non Selective Beta-Blocker

DRUG

Placebo

Placebo Once Daily along with previously prescribed Non Selective Beta Blocker

Trial Locations (1)

25304

Charleston Area Medical Center, Charleston

All Listed Sponsors
lead

CAMC Health System

OTHER